CClinicalTrials.gg
CompletedNCT01593618Updated Dec 2, 2017

Empowering Cancer Survivors Through Information Technology

An interventional study of UMFollowUp and Standard of Care in Cancer Survivor, sponsored by Masonic Cancer Center, University of Minnesota. Completed at 1 site in United States. Open to participants aged 15 Years to 28 Years. Per ClinicalTrials.gov, last updated 2017-12-02.

Sponsored by Masonic Cancer Center, University of Minnesota · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
53
Allocation
Randomized
Ages
15 Years to 28 Years
Sex
All
01

Study summary

This is a randomized controlled trial of a web-based informational intervention (UMFollowUp) for adolescent and young adult survivors of childhood cancer to improve cancer knowledge and psychosocial functioning.

Read the detailed description

Individuals randomly assigned to the control group will receive standard of care for the duration of their participation. This means they will continue to receive information regarding their diagnosis, treatments and ongoing health needs from their provider (no access to website).

Individuals randomly assigned to the treatment group will receive access to UMFollowUp, a secure, HIPAA-compliant website.

All participants will be asked to complete paper-and-pencil surveys at baseline and 9 months later to determine the impact of the web-based intervention.

02

Conditions studied

  • Cancer Survivor

Keywords

  • cancer survivor
03

In context

Lead sponsor

Masonic Cancer Center, University of Minnesota is the lead sponsor of 284 studies on the registry; 34 are open to participants now.

Of its 39 completed or terminated interventional studies of FDA-regulated products, 28 (72%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years to 28 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • History of diagnosis of hematologic malignancy or malignant neoplasm, and in disease free remission at time of recruitment.
  • Must be English-speaking and have access to a computer with internet access, and must have completed treatment at University of Minnesota Medical Center-Fairview for cancer.

Exclusion criteria

Exclusion Criteria:

  • Individual with significant visual impairments and neurologic/cognitive difficulties which limit their ability to see and under our outcome questionnaires or website content will be excluded from participation.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
53 participants (actual)

Study arms

  • Experimental
    Web-Based Intervention

    UMFollowUp - web-based internet resource for information about their diagnostic histories, recommendations for follow-up care, and tips to enhance their treatment, psychosocial and physical well-being.

    Behavioral: UMFollowUp

  • Active comparator
    Standard of Care

    Patients will receive information regarding their diagnosis, treatments, and ongoing health needs from their provider, but will not be provided access to the website.

    Other: Standard of Care

Interventions

  • BehavioralUMFollowUp

    Web-based internet resource for self-reported treatment summaries and psychosocial and physical well-being.

  • OtherStandard of Care

    Patients will receive information regarding their diagnosis, treatments, and ongoing health needs from their provider, but will not be provided access to the website.

06

What researchers measure

Primary outcomes

  1. Cancer Knowledge Survey

    Measure of patient reported knowledge of their cancer diagnosis, history and treatments.

    Time frame: Time of Enrollment and 9 Months Later

Secondary outcomes

  1. SF-36 Questionnaire

    A measure of quality of life.

    Time frame: Time of Enrollment and 9 Months Later

  2. Cancer Rehabilitation Evaluation System

    Short Form (SF) Medical Interaction Subscale

    Time frame: Time of Enrollment and 9 Months Later

  3. Herth Hope Index

    A measure of self-reported hope.

    Time frame: Time of Enrollment and 9 Months Later

  4. Multidimensional Scale of Perceived Social Support

    A measure of self-reported social support.

    Time frame: Time of Enrollment and 9 Months Later

  5. Health Locus of Control Scale

    A measure of self-reported locus of control.

    Time frame: Time of Enrollment and 9 Months Later

  6. State Trait Anxiety Inventory

    A measure of self-reported anxiety.

    Time frame: Time of Enrollment and 9 Months Later

07

Study locations

1 site
  • Masonic Cancer Center, University of Minnesota
    Minneapolis, Minnesota 55455, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 2, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01593618
Lead sponsor
Masonic Cancer Center, University of Minnesota
Responsible party
Sponsor
First posted
May 8, 2012
Start date
Aug 2007
Primary completion
Apr 2012
Completion
Apr 2012
Last update
Dec 2, 2017

Study contacts

Alicia Kunin-Batson, M.D.
principal investigator · Masonic Cancer Center, University of Minnesota

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion